attachment

Diagnosis and management

Reading File
search_medical_text

anterior STEMI ECG diagnosis ST elevation V1 V2 V3 V4 criteria

search_medical_text

STEMI management reperfusion percutaneous coronary intervention thrombolysis guidelines

search_medical_image

anterior STEMI ECG ST elevation precordial leads

GradeResponse
GradeResponse
GradeResponse

ECG Analysis

Patient: Mr. Aminul Islam, 25M | HR: 90 bpm | Date: April 02, 2026

ECG Findings

ParameterValue
Heart Rate90 bpm
PR Interval0.14 sec (normal)
QRS Duration0.076 sec (normal)
QT/QTc0.196 / 0.241 sec
P-QRS-T Axis69 / -29 / 45°
Critical findings from the tracing:
  • Massive ST elevation in the precordial leads: V1 (1.81 mm), V2 (4.96 mm), V3 (4.96 mm), V4 (3.29 mm), V5 (2.03 mm), V6 (1.86 mm)
  • ST elevation in limb leads: Lead I (0.81 mm), Lead II (1.39 mm), aVL (0.13 mm), aVF (0.90 mm)
  • Reciprocal changes: aVR shows ST depression (-1.06 mm), with inferior lead involvement suggesting extensive disease
  • Tombstone morphology of ST segments visible in mid-precordial leads

Diagnosis

Extensive Anterior STEMI (ST-Elevation Myocardial Infarction)

The ST elevation from V1 through V6, involving the lateral leads (I, II, aVF), is consistent with proximal Left Anterior Descending (LAD) artery occlusion — sometimes called a "widowmaker" MI. The involvement extending to the lateral and inferior leads suggests either a wrap-around LAD or concomitant right coronary territory involvement, making this an extensive anterior MI.
The deep ST depression in aVR (−1.06 mm) further supports proximal LAD or left main occlusion.
Anterior STEMI ECG showing ST elevation V2-V6 with tombstoning morphology
Classic anterior STEMI pattern — note tombstoning ST elevation in precordial leads with reciprocal changes (comparable pattern to the submitted ECG)

Management

This is a time-critical emergency — "Door-to-balloon time" target: ≤90 minutes

Immediate (First 10 minutes)

  1. Activate the cardiac catheterization lab immediately — call STEMI alert
  2. IV access × 2, continuous cardiac monitoring, defibrillator at bedside
  3. 12-lead ECG confirmation and serial ECGs
  4. Oxygen — if SpO₂ <90% only (avoid hyperoxia)
  5. Aspirin 300 mg loading dose (chewed)
  6. P2Y12 inhibitor loading:
    • Ticagrelor 180 mg PO (preferred), or
    • Clopidogrel 600 mg PO if ticagrelor unavailable
  7. Sublingual nitroglycerine — if BP permits (avoid if hypotensive)
  8. Morphine 2–4 mg IV for pain relief (use cautiously — may delay P2Y12 absorption)
  9. Anticoagulation: Unfractionated heparin 60 U/kg IV bolus (max 4000 U)
  10. Labs: Troponin, CBC, BMP, coagulation profile, blood type & cross

Reperfusion Strategy (Harrison's, p. 7584)

StrategyPreferred When
Primary PCI (1st choice)PCI-capable center available within 90 min of first medical contact
Fibrinolysis (fallback)PCI not available within 120 min; symptom onset <12h; no contraindications
Primary PCI is the gold standard — superior to thrombolysis in opening occluded arteries with better short- and long-term outcomes (Harrison's, p. 7584).
If fibrinolysis is chosen (no PCI available):
  • Alteplase (tPA): 15 mg IV bolus, then 0.75 mg/kg over 30 min, then 0.5 mg/kg over 60 min
  • Streptokinase: 1.5 million units over 60 min
  • Absolute contraindications: prior intracranial hemorrhage, active bleeding, recent surgery, severe uncontrolled hypertension

ICU/CCU Monitoring

  • Continuous telemetry — this young patient with proximal LAD occlusion is at high risk for:
    • Ventricular fibrillation / VT (peak risk first 24–48 h)
    • Complete heart block
    • Acute heart failure / cardiogenic shock
    • Mechanical complications: free wall rupture, VSD, acute MR

Post-Reperfusion Medical Therapy

DrugDoseIndication
Aspirin75–100 mg daily (lifelong)Antiplatelet
Ticagrelor90 mg BD × 12 monthsAntiplatelet (DAPT)
Beta-blocker (metoprolol)25–50 mg BDReduce remodeling, arrhythmia
ACE inhibitor (ramipril)2.5–10 mg dailyReduce LV remodeling
Statin (atorvastatin)40–80 mg dailyPlaque stabilization
Aldosterone antagonistIf EF ≤40% + symptomsEplerenone/spironolactone

Special Consideration — Young Patient (25 years old)

A STEMI at age 25 is uncommon and warrants investigation for:
  • Cocaine/stimulant use (coronary spasm or thrombosis)
  • Hypercoagulable state (antiphospholipid syndrome, Factor V Leiden)
  • Familial hypercholesterolemia
  • Spontaneous coronary artery dissection (SCAD)
  • Coronary artery anomaly
  • Kawasaki disease sequelae
Screen post-stabilization with lipid panel, thrombophilia workup, and toxicology if indicated.

⚠️ This ECG represents a life-threatening emergency requiring immediate activation of the STEMI protocol and urgent reperfusion.
This is a shared conversation. Sign in to Orris to start your own chat.